ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Systemic bone loss measured by routine CT is associated with increased pain, postural decompensation, and survival in multiple myeloma.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Systemic bone loss measured by routine CT is associated with increased pain, postural decompensation, and survival in multiple myeloma.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- Multiple myeloma with spinal involvement: Renal dysfunction and albuminuria are associated with progressive sarcopenia in a longitudinal CT morphometric study.Brain & spine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMultiple myeloma (MM) is frequently associated with bone loss, yet the clinical significance of vertebral body bone loss measured in Hounsfield Unit (HU) decline remains underexplored. This study aimed to investigate longitudinal changes in vertebral HU on routine CT scans, and their associations with disease-related parameters, postural alignment, function and survival.
methodsIn this retrospective study, 79 MM patients with three sequential whole-body CT scans were analyzed. HU values at vertebral level L1-L4 were assessed, and a ≥ 35% decline was identified via ROC analysis as a clinically relevant threshold influencing clinical outcomes. Subgroup analyses examined the influence of disease activity, steroid use, osteoprotective therapy, renal function, and nutritional status. Associations with pain, spinopelvic sagittal alignment, and survival were evaluated.
resultsHU values declined markedly over time, from 148.6 ± 11.3 HU at baseline to 120.1 ± 10.3 HU at tCT2 and 86.5 ± 11.8 HU at tCT3 (p < 0.0001). Patients with high disease activity showed greater HU loss than those with low activity (- 49.5 ± 8.7% vs. -38.7 ± 11.0%, p < 0.001). Steroid therapy accelerated HU decline (- 47.1 ± 7.6% vs. -40.4 ± 8.4%, p < 0.001), whereas osteoprotective treatment mitigated it (- 36.8 ± 7.2% vs. -42.3 ± 8.9%, p = 0.02). The ROC-derived threshold for clinically relevant bone loss was ≥ 35%, identifying patients with higher pain (VAS 7 vs. 4, p < 0.001), greater analgesic use (WHO score 2 vs. 1, p < 0.001), and more pronounced postural deterioration (ΔTK + 8.3° vs. -0.7°, p < 0.001; ΔLL - 10.6° vs. -2.4°, p < 0.001). In multivariate analysis, ≥ 35% HU loss was independently predicted by high disease activity (OR 2.62, p = 0.006) and steroid exposure (OR 2.11, p = 0.027), while osteoprotective therapy was protective (OR 0.53, p = 0.031). Exploratory survival analysis showed reduced overall survival in patients with ≥ 35% HU decline (p = 0.04).
conclusionCT-based HU measurement enables longitudinal assessment of vertebral bone quality and identifies patients at risk for pain, functional decline, and poorer overall prognosis. Furthermore, HU decline increases with disease progression and might serve as additional marker for disease burden and activity.
Indexed as
Identifiers
41442041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.